News
Filters:
Doctors To Test AMA’s Opposition To Medicare For All
Some physicians from within the American Medical Association want the national doctors group to consider dropping its opposition to a single payer version of “Medicare for All.”… Read More
Liberals want to build their campaign around pharmacare, but ignore where drugs would end up
Internal documents from within the Liberal Party recently showed that Ontario Liberal MPs want 2019’s election campaign to be built on a national pharmacare plan. Read More
CBO officials: ‘Medicare for All’ plan would require ‘major undertaking’
The political jockeying over “Medicare for All” continued Wednesday as a House committee hosted a second hearing on single-payer healthcare. Representatives from the Congressional Budget Office (CBO) attended the House… Read More
‘Medicare for All’ Falters as Top Democrats Fret Over Backlash
The “Medicare for All” push is hitting serious obstacles in the U.S. House in the face of resistance from Democratic leaders concerned that replacing the private insurance system would generate… Read More
U.S. Should Not Import Foreign Price Controls on Drugs
On May 20, 2019, Health and Human Services (HHS) Secretary Alex Azar, spoke before the 72nd World Health Assembly, the decision-making body of the World Health Organization (WHO) under the… Read More
Transition to ‘Medicare for All’ health care system could be complicated, say budget analysts
Democrats’ aspirations for “Medicare for All” are smashing into the harsh realities of filling in the details of who gets covered and how much it will cost taxpayers, with budget… Read More
Transition to ‘Medicare for All’ health care system could be complicated, say budget analysts
Democrats’ aspirations for “Medicare for All” are smashing into the harsh realities of filling in the details of who gets covered and how much it will cost taxpayers, with budget… Read More
‘Medicare for All’ Falters as Top Democrats Fret Over Backlash
The “Medicare for All” push is hitting serious obstacles in the U.S. House in the face of resistance from Democratic leaders concerned that replacing the private insurance system would generate… Read More
LAWS: New Drug Pricing Model Hurts Medical Innovation
Through my experience working in the policy arena at the state d federal level, including during my time at NAMI-NC and in Washington, I have seen many different policy proposals… Read More
CCAGW Leads Coalition to Oppose Using Binding Arbitration to Lower Medicare Drug Prices
On behalf of the millions of members and supporters of our respective organizations, we are writing in opposition to the use of binding arbitration to lower drug prices in Medicare… Read More